日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial

评估以全层愈合为目标治疗中重度活动性克罗恩病患者的疗效:随机对照 VECTORS 试验的原理、设计和方案

Jairath, Vipul; Vuyyuru, Sudheer K; Zou, Guangyong; Ma, Christopher; Neustifter, Blue; Agboton, Christian; Romo Bautista, Itzel; Allocca, Mariangela; An, Yoon-Kyo; Begun, Jakob; Bryant, Robert V; Danese, Silvio; Dubinsky, Marla; Feagan, Brian G; Freire, Marcelo; Novak, Kerri L; Panaccione, Remo; Pudipeddi, Aviv; Rubin, David T; Sands, Bruce E; Sparrow, Miles P; Taylor, Stuart A; Gecse, Krisztina B; Wilkens, Rune; Maaser, Christian

Therapeutic Drug Monitoring of the Subcutaneous Formulations of Infliximab and Vedolizumab-Current Knowledge and Future Directions

英夫利昔单抗和维多珠单抗皮下制剂的治疗药物监测——现状与未来方向

Massouridis, Ben; Sparrow, Miles P

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases

关于在开始使用先进疗法治疗炎症性肠病之前进行评估和疫苗接种的共识声明

Leong, Rupert W; Sakiris, Anthony; Arzivian, Arteen; Chetwood, John David; Chaemsupaphan, Thanaboon; Sparrow, Miles P; Kamm, Michael A; Kariayawasam, Viraj

IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia

IBD 2024:IBD 新航向——武田研讨会论文集,2024 年 11 月 22-23 日,澳大利亚昆士兰州布里斯班 W 酒店

Mahadevan, Uma; Jairath, Vipul; Begun, Jakob; Pudipeddi, Aviv; Garg, Mayur; De Cruz, Peter; Li Wai Suen, Christopher F D; Choy, Matthew C; Con, Danny; Vaughan, Rose; Chetwood, John D; Clark, David A; Haifer, Craig; Sparrow, Miles P; Leong, Rupert; Mountifield, Réme

Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future

综述文章:白蛋白及其在炎症性肠病中的作用:过去、现在和未来

Cameron, Karla; Nguyen, Anke L; Gibson, David J; Ward, Mark G; Sparrow, Miles P; Gibson, Peter R

Dietary Intervention Trial Design in Patients With an Ileoanal Pouch: Lessons From a Randomized, Double-Blind, Placebo-Controlled Feeding Study

回肠肛管吻合术患者的饮食干预试验设计:一项随机、双盲、安慰剂对照喂养研究的经验教训

Ardalan, Zaid S; Sparrow, Miles P; Rohani, Faran; Gibson, Peter R; Yao, Chu K

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium

澳大利亚乌司奴单抗治疗克罗恩病的真实世界疗效和安全性:AURORA 研究结果,包括 ANZIBD 联盟

An, Yoon-Kyo; Lindsay, Niamh; Allan, Natalie; Khoo, Emi; Fernandes, Richard; Gilmore, Robert; Amiss, Anna; Pham, Hai; Ooi, Soong-Yuan; Thin, Lena; Lightowler, Daniel; Connor, Susan J; Williams, Astrid; De Cruz, Peter; Li Wai Suen, Christopher F D; Kariyawasam, Viraj; Mitrev, Nikola; Ghaly, Simon; Andrews, Jane M; Christensen, Britt; Sparrow, Miles P; White, Lauren S; Bryant, Robert; Ding, Nik S; Leong, Rupert W; Van Langenberg, Daniel R; Seltenreich, Hansjoerg; Subramaniam, Kavitha; Radford-Smith, Graham; Begun, Jakob

Anaphylaxis to a Vedolizumab Infusion following Drug Holiday in a Patient with Ulcerative Colitis: A Case Report

溃疡性结肠炎患者停药后接受维多珠单抗输注发生过敏反应:病例报告

Karp, Jadon; Shen, Henry; Goodwin, Thomas; Sparrow, Miles P

Perianal Crohn's disease: Still more questions than answers

肛周克罗恩病:疑问仍多于答案

Swaminathan, Akhilesh; Sparrow, Miles P

Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial

在炎症性肠病中,从剂量强化静脉注射英夫利昔单抗转换为皮下注射英夫利昔单抗(DISCUS-IBD):一项多中心随机对照试验方案

Little, Robert D; McKenzie, Jo; Srinivasan, Ashish; Hilley, Patrick; Gilmore, Robert B; Chee, Desmond; Sandhu, Manjeet; Saitta, Daniel; Chow, Elizabeth; Thin, Lena; Walker, Gareth J; Moore, Gregory T; Lynch, Kate; Andrews, Jane; An, Yoon K; Bryant, Robert V; Connor, Susan J; Garg, Mayur; Wright, Emily K; Hold, Georgina; Segal, Jonathan P; Boussioutas, Alex; De Cruz, Peter; Ward, Mark G; Sparrow, Miles P